Cost of drugs used to treat patients in tuberculosis hospitals
Vasil'eva, I.S.; Muzyra, I.A.; Lysak, L.S.; Tikhonova, L.A.; Efron, I.I.
Problemy Tuberkuleza 10: 14-17
1982
ISSN/ISBN: 0032-9533 PMID: 6217462 Document Number: 187377
Document emailed within 1 workday
Related Documents
Takenaka, T.; Tsukamura, M. 1970: A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. a fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria Kekkaku: 45(3): 93-96Vilaseca Canais, J.; Buxeda Mestres, C.; Cámara Contreras, C.; Flor Serra, F.; Pérez Guinaldo, R.; Sánchez Viñas, M. 1997: Do the patients we treat with hypolipemic drugs have a coronary risk? Atencion Primaria 20(1): 49-53
Chino, H.; Hagiwara, E.; Sekine, A.; Kitamura, H.; Baba, T.; Shinohara, T.; Komatsu, S.; Ogura, T. 2016: [compliance Rate of Standard Treatment Regimen and Optimal Dose of Anti-Tuberculosis Drugs in Late Elderly Patients with Pulmonary Tuberculosis Kekkaku: 91(5): 495-502
Pollock, K.; Grime, J. 2000: Patients' views on cost effectiveness of drugs are important Bmj 321(7271): 1292
Sentíes, R.; Herrera Contreras, M.; Celia Aquilar, T.S. 1971: Coordination of chest clinics and hospitals for tuberculosis patients Salud Publica de Mexico 13(5): 723-727
Valdivia Alvarez, J.A.; Jimenez Misas, C.A.; Rodriguez, R.; Mederos Cuervo, L.; Echemendia Font, M.; Valdes, L.; Suarez, R.; Gonzalez, R.; Romero, V.; Heredia, C.; Tudela, H.; Hernandez, M.; Ruiz Landa, A.; Alvarez, J. 1982: Cooperative study of resistance to antibacilli drugs in M. Tuberculosis strains isolated from Tuberculosis patients. (Preliminary study) Revista Cubana de Medicina Tropical 34(2): 119-125
Tremblay, J. 1980: Prescription drugs and the aged: cost-free and cost-containment measures L'Union Medicale du Canada 109(3): 414-420
Tshamba, H.Mundongo.; a Kaut, C.Mukeng.; Kyalubile, N.Mulubwa.; Kakambal, A.Kaij.; Yav, G.Ditend.; Kaj, Fçoise.Malonga.; Vancaillie, D. 2013: Cost of hospital care for HIV/AIDS infected patients in three general reference hospitals in Lubumbashi, DR Congo: prospective cohort study Pan African Medical Journal 15: 76
Masobe, P.; Lee, T.; Price, M. 1995: Isoniazid prophylactic therapy for tuberculosis in HIV-seropositive patients--a least-cost analysis South African Medical Journal 85(2): 75-81
Moriya, A.; Usami, E.; Hirose, T.; Takenaka, S.; Asano, H.; Okada, K.; Adachi, S.; Yoshimura, T. 2019: Examination of Actual Medical Material Cost and Cost Reduction Related to Exposure Prevention in the Preparation of Anticancer Drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(8): 1281-1286
Krishnamurthy, K.; Walker, A.; Gropper, C.A.; Hoffman, C. 2010: To treat or not to treat? Management of guttate psoriasis and pityriasis rosea in patients with evidence of group a Streptococcal infection Journal of Drugs in Dermatology: Jdd 9(3): 241-250
Henry, W.F. 1993: Hospitals must shift gears to treat chronic conditions Modern Healthcare 23(19): 25
Moser, M. 1996: To treat or not treat patients with mild hypertension American Family Physician 54(8): 2370
Wolf, F.I.; Trapani, V.; Cittadini, A.; Maier, J.A.M. 2009: Hypomagnesaemia in oncologic patients: to treat or not to treat? Magnesium Research 22(1): 5-9
Kamolratanakul, P.; Hiransuthikul, N.; Singhadong, N.; Kasetjaroen, Y.; Akksilp, S.; Lertmaharit, S. 2002: Cost analysis of different types of tuberculosis patient at tuberculosis centers in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 33(2): 321-330
1979: Technical discussions at the 20th Panamerican Health Conference. Repercussions of the cost of drugs on the cost of health: national and international problems Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 87(6): 471-493
Mŏkhin, E.P.; Gimaddinov, R.Z. 1985: Treatment of patients with destructive pulmonary tuberculosis by the intracavitary administration of drugs Problemy Tuberkuleza 2: 41-43
Wagner, B.G.; Coburn, B.J.; Blower, S. 2013: Increasing survival time decreases the cost-effectiveness of using "test and treat'' to eliminate HIV epidemics Mathematical Biosciences and Engineering: Mbe 10(5-6): 1673-1686
Weiner, W.J.; Shulman, L.M.; Oertel, W.H. 1999: Do we need more drugs to treat Parkinson's disease? Advances in Neurology 80: 481-483
Kapadia, J.D.; Desai, C.K.; Solanki, M.N.; Shah, A.N.; Dikshit, R.K. 2013: Efficacy and safety of anti-tuberculosis drugs in HIV-positive patients: a prospective study Indian Journal of Pharmacology 45(5): 447-452